BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 31167116)

  • 1. Meta-analysis of related factors of impulse control disorders in patients with Parkinson's disease.
    Liu B; Luo W; Mo Y; Wei C; Tao R; Han M
    Neurosci Lett; 2019 Aug; 707():134313. PubMed ID: 31167116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of impulse control symptoms in Parkinson's disease with REM sleep behaviour disorder.
    Fantini ML; Macedo L; Zibetti M; Sarchioto M; Vidal T; Pereira B; Marques A; Debilly B; Derost P; Ulla M; Vitello N; Cicolin A; Lopiano L; Durif F
    J Neurol Neurosurg Psychiatry; 2015 Feb; 86(2):174-9. PubMed ID: 25006210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impulse Control Disorders in the Polish Population of Patients with Parkinson's Disease.
    Toś M; Grażyńska A; Antoniuk S; Siuda J
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629758
    [No Abstract]   [Full Text] [Related]  

  • 4. Impulse Control and Related Disorders in Parkinson's Disease.
    Weintraub D; Claassen DO
    Int Rev Neurobiol; 2017; 133():679-717. PubMed ID: 28802938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impulse control disorders in Parkinson's disease patients with RLS: a cross sectional-study.
    Marques A; Figorilli M; Pereira B; Derost P; Debilly B; Beudin P; Vidal T; Durif F; Fantini ML
    Sleep Med; 2018 Aug; 48():148-154. PubMed ID: 29913341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impulse control disorders in Parkinson disease: A cross-sectional study in Morocco.
    El Otmani H; Mouni FZ; Abdulhakeem Z; Attar Z; Rashad L; Saali I; El Moutawakil B; Rafai MA; Slassi I; Nadifi S
    Rev Neurol (Paris); 2019 Apr; 175(4):233-237. PubMed ID: 30935674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sleep and REM sleep behaviour disorder in Parkinson's disease with impulse control disorder.
    Fantini ML; Figorilli M; Arnulf I; Zibetti M; Pereira B; Beudin P; Puligheddu M; Cormier-Dequaire F; Lacomblez L; Benchetrit E; Corvol JC; Cicolin A; Lopiano L; Marques A; Durif F
    J Neurol Neurosurg Psychiatry; 2018 Mar; 89(3):305-310. PubMed ID: 29066517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impulse control disorder in patients with Parkinson's disease under dopamine agonist therapy: a multicentre study.
    Garcia-Ruiz PJ; Martinez Castrillo JC; Alonso-Canovas A; Herranz Barcenas A; Vela L; Sanchez Alonso P; Mata M; Olmedilla Gonzalez N; Mahillo Fernandez I
    J Neurol Neurosurg Psychiatry; 2014 Aug; 85(8):840-4. PubMed ID: 24434037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of impulse control disorders associated with levodopa-carbidopa intestinal gel treatment in advanced Parkinson's disease.
    Catalan MJ; Molina-Arjona JA; Mir P; Cubo E; Arbelo JM; Martinez-Martin P;
    J Neurol; 2018 Jun; 265(6):1279-1287. PubMed ID: 29557989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impulse control disorders in Parkinson's disease.
    Weintraub D; Potenza MN
    Curr Neurol Neurosci Rep; 2006 Jul; 6(4):302-6. PubMed ID: 16822350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impulse control disorders in Parkinson's: Sleep disorders and nondopaminergic associations.
    Carbunaru S; Eisinger RS; Ramirez-Zamora A; Bassan D; Cervantes-Arriaga A; Rodriguez-Violante M; Martinez-Ramirez D
    Brain Behav; 2018 Mar; 8(3):e00904. PubMed ID: 29541533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and psychopathological factors associated with impulse control disorders in Parkinson's disease].
    Sáez-Francàs N; Martí Andrés G; Ramírez N; de Fàbregues O; Álvarez-Sabín J; Casas M; Hernández-Vara J
    Neurologia; 2016 May; 31(4):231-8. PubMed ID: 26096669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term follow-up of impulse control disorders in Parkinson's disease.
    Mamikonyan E; Siderowf AD; Duda JE; Potenza MN; Horn S; Stern MB; Weintraub D
    Mov Disord; 2008 Jan; 23(1):75-80. PubMed ID: 17960796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term cognitive follow-up of Parkinson's disease patients with impulse control disorders.
    Siri C; Cilia R; Reali E; Pozzi B; Cereda E; Colombo A; Meucci N; Canesi M; Zecchinelli AL; Tesei S; Mariani CB; Sacilotto G; Zini M; Pezzoli G
    Mov Disord; 2015 Apr; 30(5):696-704. PubMed ID: 25757654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Behavioural and trait changes in parkinsonian patients with impulse control disorder after switching from dopamine agonist to levodopa therapy: results of REIN-PD trial.
    Lee JY; Jeon B; Koh SB; Yoon WT; Lee HW; Kwon OD; Kim JW; Kim JM; Ma HI; Kim HT; Baik JS; Cho J;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):30-37. PubMed ID: 30361296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 7-year observation of the effect of subthalamic deep brain stimulation on impulse control disorder in patients with Parkinson's disease.
    Kim A; Kim YE; Kim HJ; Yun JY; Yang HJ; Lee WW; Shin CW; Park H; Jung YJ; Kim A; Ehm G; Kim Y; Jang M; Jeon B
    Parkinsonism Relat Disord; 2018 Nov; 56():3-8. PubMed ID: 30054182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parkinson's disease polygenic risk score is not associated with impulse control disorders: A longitudinal study.
    Ihle J; Artaud F; Bekadar S; Mangone G; Sambin S; Mariani LL; Bertrand H; Rascol O; Durif F; Derkinderen P; Scherzer C; Elbaz A; Corvol JC; ; ; ; ; ; ; ;
    Parkinsonism Relat Disord; 2020 Jun; 75():30-33. PubMed ID: 32450545
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognosis of impulse control disorders in Parkinson's disease: a prospective controlled study.
    Wirth T; Goetsch T; Corvol JC; Roze E; Mariani LL; Vidailhet M; Grabli D; Mallet L; Pelissolo A; Rascol O; Brefel-Courbon C; Ory-Magne F; Arbus C; Bekadar S; Krystkowiak P; Marques A; Llorca M; Krack P; Castrioto A; Fraix V; Maltete D; Defebvre L; Kreisler A; Houeto JL; Tranchant C; Meyer N; Anheim M
    J Neurol; 2024 May; 271(5):2412-2422. PubMed ID: 38214756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapy.
    Rossi PJ; De Jesus S; Hess CW; Martinez-Ramirez D; Foote KD; Gunduz A; Okun MS
    Parkinsonism Relat Disord; 2017 Nov; 44():13-17. PubMed ID: 28827010
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine and impulse control disorders in Parkinson's disease.
    Weintraub D
    Ann Neurol; 2008 Dec; 64 Suppl 2(Suppl 2):S93-100. PubMed ID: 19127573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.